What is the recommended course of action for a 62-year-old individual not immune to Mumps (Mumps) and Rubella (German Measles)?

MMR Vaccination for a 62-Year-Old Not Immune to Mumps and Rubella

A 62-year-old individual who lacks immunity to mumps and rubella should receive one dose of MMR vaccine to establish immunity, unless contraindicated.

Assessment of Immunity Status

For adults born before 1957:

• Generally considered immune to measles and mumps due to natural infection 1, 2
• However, this presumption is not absolute, especially for rubella 3
• Laboratory evidence showing lack of immunity overrides the age-based presumption 3

Vaccination Recommendations

Primary Recommendation

• For a 62-year-old (born before 1957) without immunity to mumps and rubella:
  • Administer one dose of MMR vaccine 1, 2
  • No need for a second dose unless the individual is in a high-risk category 3

Special Considerations for High-Risk Individuals

If the individual falls into any of these categories, consider a more aggressive approach:

• Healthcare personnel: Consider 2 doses of MMR for measles/mumps immunity and at least 1 dose for rubella immunity 1, 3
• International travelers: 2 doses recommended 1
• During outbreaks: Additional dose may be warranted 3

Contraindications

Do not administer MMR vaccine if the patient has:

• Severe allergic reaction to previous dose or vaccine component 4
• Immunosuppression 4
• Moderate or severe acute illness 4
• Active untreated tuberculosis 4
• Pregnancy (should be avoided for 1 month following vaccination) 4

Expected Outcomes

After vaccination:

• High immunogenicity with seroconversion rates of 95-100% 5
• Long-lasting immunity that may be lifelong 5
• Protection from disease complications, which can be more severe in adults 6

Potential Adverse Effects

• Minor reactions may occur approximately one week after immunization 5
• Common side effects include injection site redness (12.2%), pain (11.8%), and fever (3.0%) 7
• Rarely, mumps vaccine-induced meningitis may occur (milder than wild-type infection) 5

Follow-up

• No routine post-vaccination antibody testing is recommended 1, 2
• Documentation of vaccination should be maintained as evidence of immunity 1
• No booster doses are required after establishing immunity in most cases 3

Important Caveats

• The FDA-approved MMR vaccine is administered as a subcutaneous or intramuscular injection 4
• Vaccination may not offer 100% protection from measles, mumps, and rubella infection 4
• If the individual is planning international travel, vaccination should be completed at least 2 weeks before departure 6
• For women of childbearing age, rubella immunity is particularly important to prevent congenital rubella syndrome 1, 2